Autopsy report · NCT03002506

Pharmacokinetics of Ceftolozane/Tazobactam in Patients With Burns

“Much slower recruitment than anticipated”

The sponsor’s own words in the registry.

Life of this trial

• Registered 8 months before it started.
• Ran for about 2 years 10 months before it stopped.
• 6 participants enrolled.
• Results were posted on the registry 8 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 4

Sponsor

Texas Tech University Health Sciences Center

Sponsor type

University, hospital or other

Conditions

Burns; Pharmacokinetics

Interventions

Ceftolozane/tazobactam

Participants

6

Sites

1

Countries

United States

Trials that died the same way

• Serum-derived Bovine Immunoglobulin Effect on Mucositis
  “Recruitment slower than anticipated” (98% match in meaning)
• IU Health Krannert Personalized Medicine Study
  “Slower than anticipated recruitment” (97% match in meaning)
• SMA Targeted Magnetic Stimulation Against Auditory Verbal Hallucinations
  “Slow recruitment” (92% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.